Plain-English translation of NCT03894917 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is designed to understand how advanced liver cancer behaves differently in older adults and how they respond to standard cancer treatments. Researchers will compare the experiences of patients aged 65 and older with younger patients to identify what makes treatment harder or riskier for older adults, and ultimately create personalized treatment plans that work better for this group.
Older adults with advanced liver cancer often have unique health needs and may experience more complications from treatment, but we don't have enough information about how to best care for them. This study will help doctors develop safer, more effective treatment strategies specifically designed for older patients.
You likely qualify if…
You likely don't qualify if…
You will undergo a comprehensive health assessment before you receive your standard cancer treatment. Researchers will collect information about your overall health, monitor you during treatment to see how you respond and what side effects you experience, and gather data about your cancer cells and how your body handles the medication. This is an observational study, meaning researchers are watching and learning from your existing treatment rather than testing a new drug.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment target
~84 participants
Started
September 2019
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Maggie Tomasini, MPH
Mays Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.